Where it is registered
Each register and historical list with its number of registrations and a few of them.
Romania
MS · 2 registrations · Historical list
At a glance
- Registers
- 0
- Historical lists
- 1
- Registrations
- 2
- With their own page
- 0
- Companies
- 2
All medicines with Na
Human medicines from every register that match Na by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7,209 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Naftin | United States | 1%, 2% | gel | Marketed | Legacy Pharma |
| Narcan | United States | 2MG/SPRAY, 4MG/SPRAY | spray, metered | Marketed | Emergent |
| Nardil | United States | 15MG BASE | tablet | Marketed | Parke Davis |
| Nadolol | United States | 120MG, 160MG, 20MG … | tablet | Marketed | Alembic |
| Naropin | United States | 100MG/10ML, 100MG/20ML, 150MG/20ML … | solution | Marketed | Fresenius Kabi USA |
| Natacyn | United States | 5% | suspension | Marketed | Harrow Eye |
| NataziaCombination | United States | 2MG,3MG,N/A,N/A; 3MG,2MG,2MG,1MG,N/A | tablet | Marketed | Bayer Hlthcare |
| Natroba | United States | 0.9% | suspension | Marketed | Cipher |
| Nac | Brazil | Authorised | Ems Sigma Pharma Ltda | ||
| Naloxone | United States | 0.02MG/ML, 0.4MG/ML | injectable | Marketed | Wyeth Ayerst |
| NamzaricCombination | United States | 10MG; 14MG, 10MG; 21MG, 10MG; 28MG … | capsule, extended release | Marketed | Abbvie |
| Naprelan | United States | 375MG BASE, 500MG BASE, 750MG BASE | tablet, extended release | Marketed | Twi Pharms |
| Naprosyn | United States | 25MG/ML | suspension | Marketed | Atnahs Pharma US |
| Naproxen | United States | 375MG, 500MG | tablet, delayed release | Marketed | Novitium Pharma |
| Naproxen | United States | 25MG/ML | suspension | Marketed | Novitium Pharma |
| Naproxen | United States | 250MG, 375MG, 500MG | tablet | Marketed | Pharmobedient |
| Natpar | European Union | Authorised | Takeda Pharmaceuticals International AG Ireland Branch | ||
| Nayzilam | United States | 5MG/SPRAY | spray | Marketed | Ucb INC |
| Naglazyme | United States | 5MG/5ML | injectable | Marketed | Biomarin |
| Naphcon-ACombination | United States | 0.025%; 0.3% | solution/drops | Marketed | Alcon |
| Nabumetone | United States | 1GM, 500MG, 750MG | tablet | Marketed | Sciegen Pharms |
| Naratriptan | United States | 1MG BASE, 2.5MG BASE | tablet | Marketed | Apotex Corp |
| Nateglinide | United States | 120MG, 60MG | tablet | Marketed | Rising |
| Naftin | United States | 1%, 2% | cream | Marketed | Legacy Pharma |
| Namuscla | European Union | Authorised | Lupin Europe GmbH |